Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

526.79 6.98 −1.31%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) EPS (diluted)

Alert me on EPS (diluted)

Chemed Corporation's EPS (diluted) for fiscal 2025 was $18.34, down 7.79% from $19.89 in fiscal 2024. Over the twelve months to 30 September 2026 it was $20.90. Over the past ten years it has ranged from $5.86 (fiscal 2017) to $19.89 (fiscal 2024); the current reading is higher than 82% of that period. Chemed Corporation ranks 5th of 48 Medical Care Facilities companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $18.34 (7.79%)
FY2024 $19.89 10.93%
FY2023 $17.93 8.47%
FY2022 $16.53 (1.90%)
FY2021 $16.85 (13.50%)
FY2020 $19.48 46.36%
FY2019 $13.31 8.83%
FY2018 $12.23 108.70%
FY2017 $5.86 (9.57%)
FY2016 $6.48 2.37%

Quarterly newest first

Period EPS (diluted) Change
Sep 2026 $5.45 6.24%
Jun 2026 $5.13 5.99%
Mar 2026 $4.84 (11.68%)
Dec 2025 $5.48 22.87%
43 more quarters

Against its own ten years

Low $5.86 High $19.89
Ten-year median $16.53
Current reading's percentile 82

EPS (diluted) against peers

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on CHE